BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 25468909)

  • 1. Estrogen receptor (ER)α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression.
    Drew BG; Hamidi H; Zhou Z; Villanueva CJ; Krum SA; Calkin AC; Parks BW; Ribas V; Kalajian NY; Phun J; Daraei P; Christofk HR; Hewitt SC; Korach KS; Tontonoz P; Lusis AJ; Slamon DJ; Hurvitz SA; Hevener AL
    J Biol Chem; 2015 Feb; 290(9):5566-81. PubMed ID: 25468909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipocalin 2 is essential for chronic kidney disease progression in mice and humans.
    Viau A; El Karoui K; Laouari D; Burtin M; Nguyen C; Mori K; Pillebout E; Berger T; Mak TW; Knebelmann B; Friedlander G; Barasch J; Terzi F
    J Clin Invest; 2010 Nov; 120(11):4065-76. PubMed ID: 20921623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer.
    Chakraborty S; Kaur S; Guha S; Batra SK
    Biochim Biophys Acta; 2012 Aug; 1826(1):129-69. PubMed ID: 22513004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipocalin-2 deficiency prevents endothelial dysfunction associated with dietary obesity: role of cytochrome P450 2C inhibition.
    Liu JT; Song E; Xu A; Berger T; Mak TW; Tse HF; Law IK; Huang B; Liang Y; Vanhoutte PM; Wang Y
    Br J Pharmacol; 2012 Jan; 165(2):520-31. PubMed ID: 21740414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LCN2: Versatile players in breast cancer.
    Bao Y; Yan Z; Shi N; Tian X; Li J; Li T; Cheng X; Lv J
    Biomed Pharmacother; 2024 Feb; 171():116091. PubMed ID: 38171248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights of the role of estrogen in obesity from two models of ERα deletion.
    Saavedra-Peña RDM; Taylor N; Rodeheffer MS
    J Mol Endocrinol; 2022 Apr; 68(4):179-194. PubMed ID: 35244608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte lipocalin-2 modestly effects disease severity in a mouse model of multiple sclerosis while reducing mature oligodendrocyte protein and mRNA expression.
    Kalinin S; Feinstein DL
    Neurosci Lett; 2023 Oct; 815():137497. PubMed ID: 37748675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MINDY1 promotes breast cancer cell proliferation by stabilizing estrogen receptor α.
    Tang J; Luo Y; Long G; Zhou L
    Cell Death Dis; 2021 Oct; 12(10):937. PubMed ID: 34645792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex-Specific Appetite Regulation of Lipocalin-2 in High-Fat-Diet-Induced Obese Mice.
    Miao L; Tian C; Xiong Q; Zhao J; Feng Y; Yu H; Du H
    Neuroendocrinology; 2024; 114(5):468-482. PubMed ID: 38194942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer.
    Guo P; Yang J; Jia D; Moses MA; Auguste DT
    Theranostics; 2016; 6(1):1-13. PubMed ID: 26722369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid receptor activation of the Ciz1-Lcn2 locus by long range interactions.
    Hakim O; John S; Ling JQ; Biddie SC; Hoffman AR; Hager GL
    J Biol Chem; 2009 Mar; 284(10):6048-52. PubMed ID: 19124469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effects of Stress on Hippocampal Neurogenesis and Behavior in the Absence of Lipocalin-2.
    Ferreira AC; Marques F
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A repressive role for prohibitin in estrogen signaling.
    He B; Feng Q; Mukherjee A; Lonard DM; DeMayo FJ; Katzenellenbogen BS; Lydon JP; O'Malley BW
    Mol Endocrinol; 2008 Feb; 22(2):344-60. PubMed ID: 17932104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast Cancer Endocrine Therapy Promotes Weight Gain With Distinct Adipose Tissue Effects in Lean and Obese Female Mice.
    Scalzo RL; Foright RM; Hull SE; Knaub LA; Johnson-Murguia S; Kinanee F; Kaplan J; Houck JA; Johnson G; Sharp RR; Gillen AE; Jones KL; Zhang AMY; Johnson JD; MacLean PS; Reusch JEB; Wright-Hobart S; Wellberg EA
    Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34410380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effect of Adipocyte-Secreted Factors in Activating Focal Adhesion Kinase-Mediated Cell Signaling Pathway towards Metastasis in Breast Cancer Cells.
    Mubtasim N; Gollahon L
    Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38068928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting adipocyte ESRRA promotes osteogenesis and vascular formation in adipocyte-rich bone marrow.
    Huang T; Lu Z; Wang Z; Cheng L; Gao L; Gao J; Zhang N; Geng CA; Zhao X; Wang H; Wong CW; Yeung KWK; Pan H; Lu WW; Guan M
    Nat Commun; 2024 May; 15(1):3769. PubMed ID: 38704393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testosterone Reduces Body Fat in Male Mice by Stimulation of Physical Activity Via Extrahypothalamic ERα Signaling.
    Kim NR; David K; Corbeels K; Khalil R; Antonio L; Schollaert D; Deboel L; Ohlsson C; Gustafsson JÅ; Vangoitsenhoven R; Van der Schueren B; Decallonne B; Claessens F; Vanderschueren D; Dubois V
    Endocrinology; 2021 Jun; 162(6):. PubMed ID: 33674833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FGF1 supports glycolytic metabolism through the estrogen receptor in endocrine-resistant and obesity-associated breast cancer.
    Castillo-Castrejon M; Sankofi BM; Murguia SJ; Udeme AA; Cen HH; Xia YH; Thomas NS; Berry WL; Jones KL; Richard VR; Zahedi RP; Borchers CH; Johnson JD; Wellberg EA
    Breast Cancer Res; 2023 Aug; 25(1):99. PubMed ID: 37608351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing expression of STING by ERα antagonizes LCN2 downregulation during chronic endometritis.
    Chu M; He S; Zhao H; Yin S; Liu Z; Zhang W; Liu X; Bao H
    J Reprod Immunol; 2023 Dec; 160():104167. PubMed ID: 37952294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ceruloplasmin is a novel adipokine which is overexpressed in adipose tissue of obese subjects and in obesity-associated cancer cells.
    Arner E; Forrest AR; Ehrlund A; Mejhert N; Itoh M; Kawaji H; Lassmann T; Laurencikiene J; Rydén M; Arner P;
    PLoS One; 2014; 9(3):e80274. PubMed ID: 24676332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.